Ambrisentan Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ambrisentan
A
- abrocitinib
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- adagrasib
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Agenerase (amprenavir)
- Alphagan (brimonidine ophthalmic)
- Alphagan P (brimonidine ophthalmic)
- Alunbrig (brigatinib)
- Alyq (tadalafil)
- amifostine
- amoxicillin / clarithromycin / lansoprazole
- amoxicillin / clarithromycin / omeprazole
- amoxicillin / clarithromycin / vonoprazan
- amoxicillin / omeprazole / rifabutin
- amprenavir
- amyl nitrite/sodium nitrite/sodium thiosulfate
- apalutamide
- APO-Go (apomorphine)
- APO-Go Pen (apomorphine)
- Apokyn (apomorphine)
- apomorphine
- apraclonidine ophthalmic
- Apresazide (hydralazine / hydrochlorothiazide)
- Apresoline (hydralazine)
- Arava (leflunomide)
- arginine
- arginine / ascorbic acid / citrulline
- armodafinil
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- Asparlas (calaspargase pegol)
- aspirin / omeprazole
- atazanavir
- atazanavir / cobicistat
- Atripla (efavirenz / emtricitabine / tenofovir)
- Aubagio (teriflunomide)
- avacopan
- avanafil
- Avonex (interferon beta-1a)
- Avonex Pen (interferon beta-1a)
- Avonex Prefilled Syringe (interferon beta-1a)
More about ambrisentan
- ambrisentan consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.